Literature DB >> 17000998

Monoclonal antibodies from plants: a new speed record.

Andrew Hiatt1, Michael Pauly.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17000998      PMCID： PMC1595403          DOI： 10.1073/pnas.0607089103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

Review 1.  Towards molecular farming in the future: transient protein expression in plants.

Authors:  R Fischer; C Vaquero-Martin; M Sack; J Drossard; N Emans; U Commandeur
Journal:  Biotechnol Appl Biochem       Date:  1999-10       Impact factor: 2.431

2.  Virus multiplication in plants doubly infected by potato viruses X and Y.

Authors:  W F ROCHOW; A F ROSS
Journal:  Virology       Date:  1955-05       Impact factor: 3.616

3.  Interactions between viruses and virus strains.

Authors:  C W BENNETT
Journal:  Adv Virus Res       Date:  1953       Impact factor: 9.937

4.  The problem with potency.

Authors:  Christopher Thomas Scott
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

5.  Monoclonal antibody successes in the clinic.

Authors:  Janice M Reichert; Clark J Rosensweig; Laura B Faden; Matthew C Dewitz
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

6.  Upping the ante on antibodies.

Authors:  Monya Baker
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

Review 7.  The release of genetically modified crops into the environment. Part II. Overview of ecological risk assessment.

Authors:  Anthony J Conner; Travis R Glare; Jan-Peter Nap
Journal:  Plant J       Date:  2003-01       Impact factor: 6.417

8.  Enhancement of potato virus X synthesis in doubly infected tobacco occurs in doubly infected cells.

Authors:  R M Goodman; A F Ross
Journal:  Virology       Date:  1974-03       Impact factor: 3.616

9.  Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants.

Authors:  Sylvestre Marillonnet; Carola Thoeringer; Romy Kandzia; Victor Klimyuk; Yuri Gleba
Journal:  Nat Biotechnol       Date:  2005-05-08       Impact factor: 54.908

10.  Evidence for landscape-level, pollen-mediated gene flow from genetically modified creeping bentgrass with CP4 EPSPS as a marker.

Authors:  Lidia S Watrud; E Henry Lee; Anne Fairbrother; Connie Burdick; Jay R Reichman; Mike Bollman; Marjorie Storm; George King; Peter K Van de Water
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-24       Impact factor: 11.205
View more
  14 in total

1.  Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.

Authors:  Larry Zeitlin; James Pettitt; Corinne Scully; Natasha Bohorova; Do Kim; Michael Pauly; Andrew Hiatt; Long Ngo; Herta Steinkellner; Kevin J Whaley; Gene G Olinger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome.

Authors:  Hatice Karauzum; Gang Chen; Laura Abaandou; Mahta Mahmoudieh; Atefeh R Boroun; Sergey Shulenin; V Sathya Devi; Eric Stavale; Kelly L Warfield; Larry Zeitlin; Chad J Roy; Sachdev S Sidhu; M Javad Aman
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  Second-generation HIV microbicides: continued development of griffithsin.

Authors:  Larry Zeitlin; Michael Pauly; Kevin J Whaley
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-08       Impact factor: 11.205

4.  A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxin.

Authors:  Erin K Sully; Kevin Whaley; Natasha Bohorova; Ognian Bohorov; Charles Goodman; Do Kim; Michael Pauly; Jesus Velasco; Frederick W Holtsberg; Eric Stavale; M Javad Aman; Chandra Tangudu; Francisco A Uzal; Nicholas J Mantis; Larry Zeitlin
Journal:  Toxicon       Date:  2014-09-28       Impact factor: 3.033

5.  Designed IgM from glycoengineering.

Authors:  Andrew Hiatt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-15       Impact factor: 11.205

6.  Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit.

Authors:  Joanne M O'Hara; Kevin Whaley; Michael Pauly; Larry Zeitlin; Nicholas J Mantis
Journal:  Vaccine       Date:  2011-12-22       Impact factor: 3.641

7.  Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy.

Authors:  Andrew Hiatt; Natasha Bohorova; Ognian Bohorov; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; Kevin J Whaley; Pedro A Piedra; Brian E Gilbert; Larry Zeitlin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

Review 8.  IgG-Fc glycoengineering in non-mammalian expression hosts.

Authors:  Andreas Loos; Herta Steinkellner
Journal:  Arch Biochem Biophys       Date:  2012-05-23       Impact factor: 4.013

9.  Transient co-expression of post-transcriptional gene silencing suppressors for increased in planta expression of a recombinant anthrax receptor fusion protein.

Authors:  Lucas Arzola; Junxing Chen; Kittipong Rattanaporn; James M Maclean; Karen A McDonald
Journal:  Int J Mol Sci       Date:  2011-08-05       Impact factor: 5.923

Review 10.  Multiantibody strategies for HIV.

Authors:  Andrew Hiatt; Larry Zeitlin; Kevin J Whaley
Journal:  Clin Dev Immunol       Date:  2013-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.